ACE2 and COVID-19: Accordingly, since ACE2 and TMPRSS2 polymorphisms have been associated with severe COVID-19, it would be plausible that these polymorphisms could also exhibit an association with post-COVID symptomatology, particularly fatigue and dyspnea.